BIG changes in how hypertension and dyslipidemia are managed

April 2013

You'll see BIG changes in how hypertension and dyslipidemia are managed...when the new guidelines are FINALLY released.

It's high time. There have been tons of new findings since the JNC hypertension and ATP dyslipidemia guidelines were last updated.

Look for the new versions to arrive over the next several months.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Antihypertensives BIG changes in how hypertension and dyslipidemia are managed
Headache overuse of headache meds for just a few months can actually make their headaches worse
Diabetes a possible increase in acute pancreatitis risk with gliptins (Januvia, etc) and GLP-1 agonists (Byetta, etc)
Pediatrics limiting antibiotics in kids with acute otitis media (AOM)
Pediatrics A new "black box" warning will alert prescribers NOT to use codeine in children after a tonsillectomy or adenoidectomy
Cardiology ACE inhibitors help reduce SYMPTOMS of peripheral artery disease (PAD)
Anticoagulants using the new oral anticoagulants (Pradaxa, Xarelto, Eliquis) for "off-label" uses
NSAIDs kidney risks of NSAIDs
Calcium more negative press about calcium supplements
Constipation Many myths about constipation lead to inappropriate treatment
Cardiology confusion about metoprolol prescriptions